These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22731783)

  • 1. Structure-based discovery of substituted 4,5'-bithiazoles as novel DNA gyrase inhibitors.
    Brvar M; Perdih A; Renko M; Anderluh G; Turk D; Solmajer T
    J Med Chem; 2012 Jul; 55(14):6413-26. PubMed ID: 22731783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B.
    Brvar M; Perdih A; Hodnik V; Renko M; Anderluh G; Jerala R; Solmajer T
    Bioorg Med Chem; 2012 Apr; 20(8):2572-80. PubMed ID: 22444877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.
    Ronkin SM; Badia M; Bellon S; Grillot AL; Gross CH; Grossman TH; Mani N; Parsons JD; Stamos D; Trudeau M; Wei Y; Charifson PS
    Bioorg Med Chem Lett; 2010 May; 20(9):2828-31. PubMed ID: 20356737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico discovery of 2-amino-4-(2,4-dihydroxyphenyl)thiazoles as novel inhibitors of DNA gyrase B.
    Brvar M; Perdih A; Oblak M; Masic LP; Solmajer T
    Bioorg Med Chem Lett; 2010 Feb; 20(3):958-62. PubMed ID: 20045642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
    Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
    Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
    Tomašič T; Katsamakas S; Hodnik Ž; Ilaš J; Brvar M; Solmajer T; Montalvão S; Tammela P; Banjanac M; Ergović G; Anderluh M; Peterlin Mašič L; Kikelj D
    J Med Chem; 2015 Jul; 58(14):5501-21. PubMed ID: 26098163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
    Tsai FT; Singh OM; Skarzynski T; Wonacott AJ; Weston S; Tucker A; Pauptit RA; Breeze AL; Poyser JP; O'Brien R; Ladbury JE; Wigley DB
    Proteins; 1997 May; 28(1):41-52. PubMed ID: 9144789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.
    Manchester JI; Dussault DD; Rose JA; Boriack-Sjodin PA; Uria-Nickelsen M; Ioannidis G; Bist S; Fleming P; Hull KG
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5150-6. PubMed ID: 22814212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 4.2 kDa synthetic peptide as a potential probe to evaluate the antibacterial activity of coumarin drugs.
    Scatigno AC; Garrido SS; Marchetto R
    J Pept Sci; 2004 Sep; 10(9):566-77. PubMed ID: 15473264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico fragment-based discovery of indolin-2-one analogues as potent DNA gyrase inhibitors.
    Oblak M; Grdadolnik SG; Kotnik M; Jerala R; Filipic M; Solmajer T
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5207-10. PubMed ID: 16203145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging structural information for the discovery of new drugs: computational methods.
    Nguyen TB; Wong SE; Lightstone FC
    Methods Mol Biol; 2012; 841():209-34. PubMed ID: 22222454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scintillation proximity assay amenable for screening and characterization of DNA gyrase B subunit inhibitors.
    Gevi M; Domenici E
    Anal Biochem; 2002 Jan; 300(1):34-9. PubMed ID: 11743689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy.
    Sherer BA; Hull K; Green O; Basarab G; Hauck S; Hill P; Loch JT; Mullen G; Bist S; Bryant J; Boriack-Sjodin A; Read J; DeGrace N; Uria-Nickelsen M; Illingworth RN; Eakin AE
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7416-20. PubMed ID: 22041057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferred NOE and saturation transfer difference NMR studies of novobiocin binding to EnvZ suggest binding mode similar to DNA gyrase.
    Plesniak LA; Botsch K; Leibrand M; Kelly M; Sem D; Adams JA; Jennings P
    Chem Biol Drug Des; 2008 Jan; 71(1):28-35. PubMed ID: 18093089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone oxime ester derivatives.
    Liu XH; Cui P; Song BA; Bhadury PS; Zhu HL; Wang SF
    Bioorg Med Chem; 2008 Apr; 16(7):4075-82. PubMed ID: 18262793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the conformational changes of the ATP binding site of gyrase B from Escherichia coli complexed with different established inhibitors by using molecular dynamics simulation: protein-ligand interactions in the light of the alanine scanning and free energy decomposition methods.
    Saíz-Urra L; Cabrera MA; Froeyen M
    J Mol Graph Model; 2011 Feb; 29(5):726-39. PubMed ID: 21216167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors.
    Lübbers T; Angehrn P; Gmünder H; Herzig S
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4708-14. PubMed ID: 17632001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus.
    Janupally R; Jeankumar VU; Bobesh KA; Soni V; Devi PB; Pulla VK; Suryadevara P; Chennubhotla KS; Kulkarni P; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Nov; 22(21):5970-87. PubMed ID: 25288496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of enzymology in a structure-based drug discovery program: bacterial DNA gyrase.
    Cunningham ML
    Methods Mol Biol; 2012; 841():179-207. PubMed ID: 22222453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
    Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW
    Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.